Clinical trial
Aspirin and Statins for Prevention of Atherosclerosis and Arterial…
NCT00371501 · Tuen Mun Hospital, Other · Completed
Key facts
| NCT number | NCT00371501 |
|---|---|
| Title | Aspirin and Statins for Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus Erythematosus |
| Official title | Low Dose Aspirin and Statins for Primary Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus Erythematosus: A Randomized Double-blind Placebo-controlled Trial |
| Lead sponsor | Tuen Mun Hospital, Other |
| Collaborators | AstraZeneca Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Atherosclerosis, Thromboembolism, Systemic Lupus Erythematosus |
| Intervention type | Drug |
| Interventions | Rosuvastatin, placebo, aspirin |
| Enrollment | 72 |
| Start date | Jun 1, 2006 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Sep 4, 2006 |
| Last update posted | Sep 16, 2010 |
| Countries | Hong Kong |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: